Category Archives: For patients

Useful entries for patients. Dr Savatta’s most useful patient related entries.

Intuitive Robot Probe Threatens Trend-Setting Surgeries – Bloomberg

Posted on March 2, 2013 by Dr. Savatta

The safety of robots made by Intuitive Surgical Inc. (ISRG) is being probed by U.S. regulators, raising questions about the prospects of one of the hottest technologies in health care. The Food and Drug Administration asked surgeons at key hospitals … Continue reading →

Posted in For patients | Leave a comment

Green Tea May Inhibit Prostate Cancer Tumor Growth – Renal and Urology News

Posted on October 21, 2012 by Dr. Savatta

Drinking green tea may play a role in the inhibition of prostate cancer tumor growth, according to a study presented at the American Association for Cancer Research’s International Conference on Frontiers in Cancer Prevention Research in Anaheim, Calif. via Green … Continue reading →

Posted in For patients, Prostate Cancer | Tagged , | Leave a comment

Domenico Savatta, MD FACS selected as “Top Cancer Doctor”

Posted on August 5, 2012 by Dr. Savatta

Domenico Savatta, M.D., graduated Tau Beta Pi, and summa cum Laude from The Cooper Union with a B.S. in engineering. He then attended SUNY Stony Brook School of Medicine and was an AOA graduate. Thereafter, he completed a residency in … Continue reading →

Posted in For patients | Tagged , | Leave a comment

They got it wrong again – www.phillyburbs.com: Reader Voices

Posted on June 7, 2012 by Dr. Savatta

While prostate cancer is still the second leading cause of death for American men, early detection and advanced treatments have combined to reduce the mortality rate from prostate cancer by nearly 40 percent in the last two decades. During that … Continue reading →

Posted in For patients, Prostate Cancer | Tagged , , | Leave a comment

Urologists Condemn Task Forces Anti-PSA Testing Stance

Posted on May 26, 2012 by Dr. Savatta

The U.S. Preventive Services Task Force (USPSTF) on May 21 released its final recommendations on PSA-based screening forprostate cancer (PCa), which advises against the practice and gives it a grade D rating, meaning the task force believes there is “moderate … Continue reading →

Posted in For patients, Prostate Cancer | Tagged , , | Leave a comment

Prostate-Cancer Mortality at 11 Years of Follow-up — NEJM

Posted on March 18, 2012 by Dr. Savatta

After a median follow-up of 11 years in the core age group, the relative reduction in the risk of death from prostate cancer in the screening group was 21% rate ratio, 0.79; 95% confidence interval [CI], 0.68 to 0.91; P=0.001, … Continue reading →

Posted in For patients, Prostate Cancer | Tagged , , | Leave a comment